There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...

Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...

Eli Lilly intensifies its legal efforts against compounding pharmacies producing copycat versions of its weight-loss drugs, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as ...

Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...